Braveheart Bio announced it will present two key studies on its heart drug BHB-1893 at the American Heart Association Scientific Sessions 2026. The presentations include 52-week extension data on BHB-1893's efficacy and safety in treating obstructive hypertrophic cardiomyopathy (HCM), as well as new findings on its effects in non-obstructive HCM. These updates highlight progress in developing next-generation treatments for serious cardiovascular diseases. Presentation materials will be available on Braveheart Bio's website after the conference.
Braveheart Bio's upcoming presentations at the American Heart Association Scientific Sessions 2026 provide context for health sector activity. For readers following health stocks, 75 of 150 priced US health-sector stocks rose while 70 fell today. Notable movers include Illumina, Inc. (ILMN) down 14.07%, Cassava Sciences Inc (FLNA) up 100% buy activity with a price drop of 10.19%, and Stryker Corporation (SYK) down 9.47%. Data is as of Oct 30, 2026 18:11 WIB.
Oxford Square Capital Corp. announced its financial results for Q3 2026, reporting a net asset value (NAV) per share of $1.21, down from $1.29 in Q2. The company declared monthly dividends of $0.015 per share for January, February, and March 2027. Ne...
MADD Canada warns Canadians to avoid impaired driving during Halloween, emphasizing the risks of alcohol, cannabis, and drug-related crashes that cause deaths and injuries annually. The organization urges people to plan safe rides, watch for children...
As Halloween approaches, MADD Canada warns against impaired driving caused by alcohol, cannabis, or drugs, which leads to hundreds of deaths and thousands of injuries annually in Canada. The organization urges people to plan safe transportation if co...
Investec Bank Plc, acting as joint broker for SThree Plc, disclosed share transactions on October 29, 2026. The bank purchased and sold 49,799 ordinary shares of SThree Plc at prices ranging between 297.5 and 306.5 per share. No derivative or option ...
Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed its share dealings on October 29, 2026. The bank purchased 218,193 ordinary shares at prices between 1091 and 1094 pence per share and sold 160,410 shares at prices bet...
